-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Ineffective Erythropoiesis in Thalassemia and Sickle Cell Disease

Program: Marquee Sessions
Session: 2024 Presidential Symposium
Tuesday, December 10, 2024, 9:45 AM-11:15 AM

Olivier Hermine, MD, PhD

Laboratory of physiopathology of hematological disorders and their therapeutic implications, IMAGINE institute Paris France, Paris, France

Disclosures: Hermine: BMS: Research Funding; Alexion: Research Funding; Roche: Research Funding; Inatherys: Consultancy, Current equity holder in publicly-traded company, Patents & Royalties, Research Funding; MSD Avenir: Research Funding; AB Science: Consultancy, Current equity holder in publicly-traded company, Patents & Royalties, Research Funding.

See more of: 2024 Presidential Symposium
See more of: Marquee Sessions
<< Previous Presentation | Next Presentation